The present study suggests the advantage of adding a 0.0125 mg/Kg r-hGH daily dose to the standard therapy versus the standard therapy alone in a subset of severe fibromyalgia patients with low IGF-1 serum levels. The gene discussed is IGF1; the disease is fibromyalgia.